CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cytosorbents (CTSO) Misses Q1 EPS by 1c
May 14, 2025 4:03 PM EDTCytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $10.82 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More
